TY - JOUR
T1 - Coronary microvascular dysfunction beyond microvascular obstruction in ST-elevation myocardial infarction: Functional and clinical correlates
AU - Locorotondo, G.
AU - Galiuto, L.
AU - Porto, I.
AU - Fedele, E.
AU - Paraggio, L.
AU - Rebuzzi, A. G.
AU - Crea, F.
PY - 2021
Y1 - 2021
N2 - Objectives: To retrospectively characterize clinical predictors and impact on left ventricular (LV) ejection fraction (EF) of microvascular dysfunction (MVD) beyond microvascular obstruction (MVO), in 49 consecutive patients (58 ± 11 years), with successfully treated ST-elevation myocardial infarction. Methods: By myocardial contrast echocardiography, MVD was considered as myocardial segments with delayed/patchy opacification, while MVO as areas without any opacification. Both MVD and MVO were planimetered and expressed as percentage of total LV wall area. Patients were divided into tertiles of MVO: I (MVO 0%), II (MVO 4–17%), and III (MVO 18–38%) groups. Cardiac troponin T (cTnT) values obtained at admission and at peak were considered for analysis. Results: MVD correlated inversely with EF in groups I and II (p = 0.025, p = 0.019, respectively), but not in group III. MVD was independently predicted by cTnT on admission (β = 1.85; 95%CI = 0.46–3.24, p = 0.011) and female sex (β for male sex = −14.46; 95% CI = −27.96–0.95), while MVO by anterior MI (β = 0.57; 95% CI = 0.26–0.88, p = 0.008) and peak cTnT (β = 0.97; 95%CI = 0.57–1.38, p < 0.001). Altogether, MVD plus MVO predicted EF (β = −0.18; 95%CI = −0.28--0.07, p = 0.002). Conclusions: Even in patients with limited amount of MVO, EF may be impaired by MVD. MVO and MVD have different predictors, which probably reflect their different pathogenesis.
AB - Objectives: To retrospectively characterize clinical predictors and impact on left ventricular (LV) ejection fraction (EF) of microvascular dysfunction (MVD) beyond microvascular obstruction (MVO), in 49 consecutive patients (58 ± 11 years), with successfully treated ST-elevation myocardial infarction. Methods: By myocardial contrast echocardiography, MVD was considered as myocardial segments with delayed/patchy opacification, while MVO as areas without any opacification. Both MVD and MVO were planimetered and expressed as percentage of total LV wall area. Patients were divided into tertiles of MVO: I (MVO 0%), II (MVO 4–17%), and III (MVO 18–38%) groups. Cardiac troponin T (cTnT) values obtained at admission and at peak were considered for analysis. Results: MVD correlated inversely with EF in groups I and II (p = 0.025, p = 0.019, respectively), but not in group III. MVD was independently predicted by cTnT on admission (β = 1.85; 95%CI = 0.46–3.24, p = 0.011) and female sex (β for male sex = −14.46; 95% CI = −27.96–0.95), while MVO by anterior MI (β = 0.57; 95% CI = 0.26–0.88, p = 0.008) and peak cTnT (β = 0.97; 95%CI = 0.57–1.38, p < 0.001). Altogether, MVD plus MVO predicted EF (β = −0.18; 95%CI = −0.28--0.07, p = 0.002). Conclusions: Even in patients with limited amount of MVO, EF may be impaired by MVD. MVO and MVD have different predictors, which probably reflect their different pathogenesis.
KW - Coronary Circulation
KW - Echocardiography
KW - Female
KW - Humans
KW - Male
KW - Microcirculation
KW - Retrospective Studies
KW - ST Elevation Myocardial Infarction
KW - Stroke Volume
KW - cardiac troponin T
KW - microvascular dysfunction
KW - microvascular obstruction
KW - myocardial perfusion defect
KW - Coronary Circulation
KW - Echocardiography
KW - Female
KW - Humans
KW - Male
KW - Microcirculation
KW - Retrospective Studies
KW - ST Elevation Myocardial Infarction
KW - Stroke Volume
KW - cardiac troponin T
KW - microvascular dysfunction
KW - microvascular obstruction
KW - myocardial perfusion defect
UR - https://publicatt.unicatt.it/handle/10807/204002
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85105208677&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105208677&origin=inward
U2 - 10.1111/micc.12696
DO - 10.1111/micc.12696
M3 - Article
SN - 1073-9688
VL - 28
SP - e12696-N/A
JO - Microcirculation
JF - Microcirculation
IS - 5
ER -